Blockchain Registration Transaction Record
ABVC BioPharma Secures Patent Protection and $667M Licensing Agreement for Botanical Depression Treatment
ABVC BioPharma secures new patent protection for ABV-1504, a botanical-based depression treatment, and enters a $667M global licensing agreement with AiBtl BioPharma. This news showcases the company's commitment to innovation and global expansion in the pharmaceutical industry.

This news matters as it highlights ABVC BioPharma's innovative botanical drug platform, providing a safer and more effective treatment option for individuals suffering from depression. The new patent and licensing agreement signify the company's strategic growth and potential global impact in the pharmaceutical market.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0x86487f90a070fe2ea5d0922ae3487afb4e31d13a16a4cbba76f67e94513ef84d |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | oxencE4T-b9043d655f66110f56ba6ebdfb1a30ed |